Detalles de la búsqueda
1.
Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study.
BMC Nephrol;
23(1): 166, 2022 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35490226
2.
Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia.
Cardiovasc Diabetol;
20(1): 139, 2021 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34243779
3.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol;
20(1): 159, 2021 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332558
4.
Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea).
Diabetes Obes Metab;
23(2): 455-466, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118320
5.
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab;
23(6): 1431-1435, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606906
6.
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence.
Diabetes Obes Metab;
22(12): 2364-2374, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32744392
7.
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study.
J Med Internet Res;
22(7): e18548, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673242
8.
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry.
Diabetes Obes Metab;
21(8): 1985-1989, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968543
9.
Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin.
Diabetes Obes Metab;
21(2): 227-233, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30101553
10.
Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy.
Support Care Cancer;
27(2): 687-696, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056531
11.
All-cause and diabetes-related healthcare costs among US adults with type 2 diabetes initiating exenatide once weekly or insulin glargine.
Diabetes Obes Metab;
20(3): 672-680, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29083520
12.
Comparative effectiveness of once-weekly glucagon-like peptide-1 receptor agonists with regard to 6-month glycaemic control and weight outcomes in patients with type 2 diabetes.
Diabetes Obes Metab;
20(2): 468-473, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28862808
13.
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
Diabetes Obes Metab;
20(8): 1983-1987, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29569378
14.
Randomised, blinded, cross-over evaluation of the palatability of and preference for different potassium binders in participants with chronic hyperkalaemia in the USA, Canada and Europe: the APPETIZE study.
BMJ Open;
14(2): e074954, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38387989
15.
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study.
BMJ Open;
13(5): e067386, 2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217263
16.
Understanding Patient Perspectives of the Impact of Anemia in Chronic Kidney Disease: A United States Patient Survey.
J Patient Exp;
9: 23743735221092629, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35425851
17.
Contemporary outcomes of anemia in US patients with chronic kidney disease.
Clin Kidney J;
15(2): 244-252, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145639
18.
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study.
Clin Kidney J;
15(4): 738-746, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35371463
19.
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.
Diabetes Res Clin Pract;
183: 109152, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34813910
20.
Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials.
Adv Ther;
39(1): 193-220, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34881414